| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
6,346 |
6,231 |
$2.72M |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
6,860 |
6,622 |
$526K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,332 |
10,321 |
$311K |
| 87486 |
|
6,398 |
6,282 |
$234K |
| 87581 |
|
6,394 |
6,278 |
$233K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,449 |
2,279 |
$172K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
367 |
364 |
$129K |
| 88312 |
|
2,099 |
1,872 |
$108K |
| 87481 |
|
1,097 |
1,028 |
$106K |
| 88341 |
|
1,093 |
1,039 |
$65K |
| 88173 |
|
2,218 |
1,956 |
$62K |
| 88304 |
|
1,471 |
1,351 |
$51K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,376 |
1,358 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,364 |
1,346 |
$46K |
| 87511 |
|
1,027 |
1,016 |
$38K |
| 88360 |
|
741 |
689 |
$34K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
928 |
916 |
$33K |
| 88342 |
|
1,510 |
1,455 |
$29K |
| 87631 |
|
306 |
305 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
238 |
238 |
$14K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
556 |
552 |
$13K |
| 87507 |
|
28 |
27 |
$12K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
636 |
634 |
$10K |
| 87505 |
|
44 |
42 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
697 |
644 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
36 |
36 |
$3K |
| 88313 |
|
38 |
36 |
$2K |
| 87510 |
|
92 |
91 |
$2K |
| 87480 |
|
92 |
91 |
$2K |
| 87660 |
|
92 |
91 |
$2K |
| 88374 |
|
143 |
142 |
$1K |
| 87150 |
|
26 |
26 |
$539.24 |
| 87081 |
|
14 |
14 |
$71.54 |